KEZAR LIFE SCIENCES INC (KZR)
US49372L1008 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to KZR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.9. This target is 1340.68% above the current price.
KZR was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about KZR.
In the previous month the buy percentage consensus was at a similar level.
KZR was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-05 | JonesTrading | Downgrade | Buy -> Hold |
| 2023-09-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-11 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-16 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | Wells Fargo | Maintains | Overweight |
| 2022-08-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-28 | Wells Fargo | Maintains | Overweight |
| 2022-05-13 | Wells Fargo | Maintains | Overweight |
| 2022-05-04 | Wells Fargo | Maintains | Overweight |
| 2021-12-08 | Wells Fargo | Initiate | Overweight |
| 2021-11-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-20 | JonesTrading | Initiate | Buy |